Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: Role of IL-1β and TGF-2

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 9, 2014, Pages C859-C877

  Nie, Linghui ^a   Lyros, Orestis ^a   Medda, Rituparna ^a   Jovanovic, Nebojsa ^a   Schmidt, Jamie L ^a   Otterson, Mary F ^a   Johnson, Christopher P ^a   Behmaram, Behnaz ^a   Shaker, Reza ^a   Rafiee, Parvaneh ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

EAC; EndoMT; HEMEC; IL 1; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; COLLAGEN 1 ALPHA 2; COLLAGEN TYPE 1; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VIMENTIN; VON WILLEBRAND FACTOR; AUTACOID; VASCULOTROPIN A;

ARTICLE; CANCER STAGING; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CELL TRANSFORMATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN ESOPHAGEAL MICROVASCULAR ENDOTHELIAL CELL; IMMUNOFLUORESCENCE; MICROVASCULATURE; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; ESOPHAGUS TUMOR; MESODERM; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MESODERM; TRANSFORMING GROWTH FACTOR BETA2; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908544314     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00081.2014     Document Type: Article

References (32)

1. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 95: 459-470, 2004.
2. Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 57: 1509-1517, 2008.
3. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
4. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177, 2003.
5. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
6. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 278: 8508-8515, 2003.
7. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2009.
8. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
9. Kleespies A, Guba M, Jauch KW, Bruns CJ. Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 87: 95-104, 2004.
10. Klein-Goldberg A, Maman S, Witz IP. The role played by the microenvironment in site-specific metastasis. Cancer Lett 352: 54-58, 2013.
11. Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 121: 3317-3324, 2008.
12. Kordes S, Cats A, Meijer SL, van Laarhoven HW. Targeted therapy for advanced esophagogastric adenocarcinoma. Crit Rev Oncol Hematol 90: 68-76, 2013.
13. Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576-590, 2011.
14. Lee JG, Ko MK, Kay EP. Endothelial mesenchymal transformation mediated by IL-1beta-induced FGF-2 in corneal endothelial cells. Exp Eye Res 95: 35-39, 2012.
15. Lorusso G, Ruegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103, 2008.
16. Lyros O, Mueller A, Heidel F, Schimanski CC, Gockel I, Galle PR, Lang H, Moehler M. Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways. Int J Cancer 127: 1197-1208, 2010.
17. Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC. IL-1beta and TGFbeta2 synergistically induce endothelial to mesenchymal transition in an NFkappaB-dependent manner. Immunobiology 218: 443-454, 2013.
18. Mihira H, Suzuki HI, Akatsu Y, Yoshimatsu Y, Igarashi T, Miyazono K, Watabe T. TGF-beta-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. J Biochem 151: 145-156, 2012.
19. O’Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 100: 1257-1264, 2005.
20. Ogawa H, Binion DG, Heidemann J, Theriot M, Fisher PJ, Johnson NA, Otterson MF, Rafiee P. Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol 288: C272-C281, 2005.
21. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379, 2008.
22. Rafiee P, Ogawa H, Heidemann J, Li MS, Aslam M, Lamirand TH, Fisher PJ, Graewin SJ, Dwinell MB, Johnson CP, Shaker R, Binion DG. Isolation and characterization of human esophageal microvascular endothelial cells: mechanisms of inflammatory activation. Am J Physiol Gastrointest Liver Physiol 285: G1277-G1292, 2003.
23. Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. Inflammation-induced endothelialto-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol 179: 2660-2673, 2011.
24. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
25. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisua-Belmonte JC, de la Pompa JL. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18: 99-115, 2004.
26. Tonra JR, Hicklin DJ. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy. Immunol Invest 36: 3-23, 2007.
27. Tougeron D, Richer JP, Silvain C. Management of esophageal adenocarcinoma. J Visc Surg 148: e161-170, 2011.
28. Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101: 816-829, 2007.
29. Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 9: 1658-1667, 2011.
30. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associ-ated fibroblasts. Cancer Res 67: 10123-10128, 2007.
31. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007.
32. Zhang J, Liu J. Tumor stroma as targets for cancer therapy. Pharmacol Ther 137: 200-215, 2013.